John A. Lust
Impact in
- Hematology top 0.01%
- Multiple Myeloma Research and Treatments
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 165
- Multiple Myeloma Research and Treatments 153
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 69
- Protein Degradation and Inhibitors 35
- Co-authors
- Robert A. Kyle (153 shared papers)Martha Q. Lacy (172 shared papers)Morie A. Gertz (174 shared papers)S. Vincent Rajkumar (178 shared papers)Angela Dispenzieri (175 shared papers)Philip R. Greipp (106 shared papers)Thomas E. Witzig (86 shared papers)Shaji Kumar (147 shared papers)
- Journals
- Blood (85 papers)Journal of Clinical Oncology (28 papers)American Journal of Hematology (24 papers)Mayo Clinic Proceedings (16 papers)Leukemia (15 papers)
- Partner nations
- United StatesCanadaItaly
In The Last Decade
John A. Lust
256 papers receiving 19.1k citations
John A. Lust's Hit Papers
Peers
Comparison fields: 5 of 165
- Hematology 11.4k
- Genetics 3.0k
- Oncology 6.0k
- Molecular Biology 11.2k
- Nephrology 1.0k
Countries citing papers authored by John A. Lust
This map shows the geographic impact of John A. Lust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Lust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Lust more than expected).
Fields of papers citing papers by John A. Lust
This network shows the impact of papers produced by John A. Lust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Lust. The network helps show where John A. Lust may publish in the future.
Co-authors
The 25 scholars most cited alongside John A. Lust, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 262 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Review of 1027 Patients With Newly Diagnosed Multiple Myeloma Hit paper breakdown → | 2003 | 1734 |
| 2 | Improved survival in multiple myeloma and the impact of novel therapies Hit paper breakdown → | 2007 | 1722 |
| 3 | Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients Hit paper breakdown → | 2013 | 981 |
| 4 | Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements Hit paper breakdown → | 2012 | 758 |
| 5 | Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis Hit paper breakdown → | 2004 | 671 |
| 6 | POEMS syndrome: definitions and long-term outcome Hit paper breakdown → | 2003 | 553 |
| 7 | A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and Colchicine Hit paper breakdown → | 1997 | 517 |
| 8 | Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma Hit paper breakdown → | 2005 | 501 |
| 9 | 2002 | 424 | |
| 10 | 1998 | 410 | |
| 11 | 1992 | 353 | |
| 12 | 2004 | 275 | |
| 13 | Prognostic value of bone marrow angiogenesis in multiple myeloma. | 2000 | 275 |
| 14 | 2002 | 273 | |
| 15 | Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. | 2002 | 253 |
| 16 | 2009 | 241 | |
| 17 | 2009 | 226 | |
| 18 | 2009 | 216 | |
| 19 | 2006 | 211 | |
| 20 | 2005 | 208 |
About John A. Lust
John A. Lust is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Immunology, having authored 262 papers that have together received 19.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (153 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (69 papers), Protein Degradation and Inhibitors (35 papers), Cancer Treatment and Pharmacology (32 papers), Chronic Lymphocytic Leukemia Research (26 papers), Peptidase Inhibition and Analysis (23 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (17 papers) and Neuroendocrine Tumor Research Advances (16 papers). The work is most often cited by research in Hematology (11.4k citations), Genetics (3.0k citations), Oncology (6.0k citations), Molecular Biology (11.2k citations) and Nephrology (1.0k citations). John A. Lust has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Robert A. Kyle, Martha Q. Lacy, Morie A. Gertz, S. Vincent Rajkumar, Angela Dispenzieri, Philip R. Greipp, Thomas E. Witzig, Shaji Kumar, Rafaël Fonseca and Suzanne R. Hayman. Their work appears in journals such as Blood, Journal of Clinical Oncology, American Journal of Hematology, Mayo Clinic Proceedings and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.